

浏览全部资源
扫码关注微信
1.上海中医药大学 附属岳阳中西医结合医院,上海 200437
2.上海市普陀区中心医院,上海 200062
Received:06 February 2021,
Published Online:09 April 2021,
Published:05 June 2021
移动端阅览
何艺韵,殷亦男,曾海荣等.柴胡皂苷A通过Wnt/β-catenin通路改变A549/DDP细胞耐药性[J].中国实验方剂学杂志,2021,27(11):83-88.
HE Yi-yun,YIN Yi-nan,ZENG Hai-rong,et al.Saikosaponin A Changes Drug Resistance of A549/DDP Cells Through Wnt/β-Catenin Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2021,27(11):83-88.
何艺韵,殷亦男,曾海荣等.柴胡皂苷A通过Wnt/β-catenin通路改变A549/DDP细胞耐药性[J].中国实验方剂学杂志,2021,27(11):83-88. DOI:
HE Yi-yun,YIN Yi-nan,ZENG Hai-rong,et al.Saikosaponin A Changes Drug Resistance of A549/DDP Cells Through Wnt/β-Catenin Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2021,27(11):83-88. DOI:
目的
2
探讨柴胡皂苷A(SSA)逆转人肺癌顺铂(DDP)耐药株A549/DDP的作用及机制。
方法
2
细胞增殖与活性检测(CCK-8)法检测A549和A549/DDP对DDP的耐药性及SSA对A549和A549/DDP细胞活力的影响;流式细胞术检测A549/DDP凋亡率和细胞中活性氧(ROS)的变化;实时荧光定量聚合酶链反应(Real-time PCR)检测C-myc,B淋巴细胞瘤-2(Bcl-2)和含半胱氨酸的天冬氨酸蛋白水解酶-3(Caspase-3) mRNA的表达情况;TopFish双荧光素酶报告基因检测
β
-连环蛋白(
β
-catenin)的转录活性;蛋白免疫印迹法(Western blot)法检测A549/DDP细胞中
β
-catenin蛋白的变化。
结果
2
CCK-8检测结果显示,A549/DDP的耐药性是A549的12.82倍,差异具有统计学意义(
P
<
0.05),SSA能够抑制A549的细胞活力,其半数抑制浓度(IC
50
)为34.9 μmol·L
-1
。SSA抑制 A549/DDP细胞的活力并具有浓度依赖性,在20 μmol·L
-1
浓度时,对A549/DDP的抑制率
<
10%,选择20 μmol·L
-1
作为逆转浓度;流式结果显示,与空白组比较,DDP组A549/DDP的凋亡比例明显升高,细胞内活性氧的累积明显增加(
P
<
0.05),与DDP组比较,SSA+DDP组A549/DDP的凋亡比例明显升高,细胞内活性氧的累积明显增加;与空白组比较,DDP组A549/DDP细胞中C-myc,Bcl-2 mRNA表达明显降低,Caspase-3 mRNA表达明显升高(
P
<
0.05),与DDP组比较,SSA+DDP组C-myc,Bcl-2 mRNA表达明显降低,Caspase-3 mRNA表达明显升高(
P
<
0.05);与空白组比较,DDP组
β
-catenin的转录活性明显降低(
P
<
0.05),与DDP组比较,SSA+DDP组
β
-catenin的转录活性明显降低(
P
<
0.05);与空白组和DDP组比较,SSA+DDP组
β
-catenin蛋白表达明显降低,差异有统计学意义(
P
<
0.05)。
结论
2
柴胡皂苷A可以提高A549/DDP细胞对DDP的敏感性,其作用机制可能与抑制Wnt/
β
-catenin信号通路激活有关。
Objective
2
To investigate the effect and mechanism of saikosaponin A (SSA) on the reversal of cisplatin (DDP) resistance in human lung cancer cell line A549/DDP.
Methods
2
The resistance of A549 and A549/DDP cells to DDP and the inhibitory effects of SSA against the proliferation of A549 and A549/DDP cells were detected using cell counting kit-8 (CCK-8). The apoptosis rates of A549/DDP cells treated with SSA or DDP or SSA combined with DDP and the changes in reactive oxygen species (ROS) were determined by flow cytometry. The mRNA expression levels of C-myc, B-cell lymphoma 2 (Bcl-2) and cysteinyl aspartate-specific protease-3 (Caspase-3) were detected by real-time polymerase chain reaction (Real-time PCR), followed by the determination of
β
-catenin transcriptional activity using the TopFish dual-luciferase reporter assay system and the measurement of
β
-catenin protein expression in A549/DDP cells by Western blot.
Results
2
The results of CCK-8 assay showed that the DDP resistance of A549/DDP cells was 12.82 times that of A549 cells (
P
<
0.05). SSA inhibited the viability of A549 cells with the half maximal inhibitory concentration (IC
50
) being 34.9 μmol·L
-1
, and also suppressed the viability of A549/DDP cells in a concentration-dependent manner. Since the inhibition rate of 20 μmol/L SSA against A549/DDP cells was less than 10%, the reversal concentration was set at 20 μmol/L. Flow cytometry revealed that compared with the control, DDP alone increased the apoptosis rate of A549/DDP cells (
P
<
0.05), stimulated the accumulation of intracellular ROS (
P
<
0.05), down-regulated the mRNA expression levels of C-myc and Bcl-2 in A549/DDP cells, up-regulated Caspase-3 mRNA expression, and reduced the transcriptional activity of
β
-catenin (
P
<
0.05). Compared with the DDP group, the SSA+DDP group exhibited obviously increased apoptosis of A549/DDP cells, enhanced accumulation of intracellular ROS, down-regulated C-myc and Bcl-2 mRNA expression, up-regulated Caspase-3 mRNA expression (
P
<
0.05), and weakened
β
-catenin transcription (
P
<
0.05). DDP combined with SSA better decreased the
β
-catenin protein expression in contrast to that of control or DDP (
P
<
0.05).
Conclusions
2
SSA enhances the sensitivity of A549/DDP cells to DDP possibly by inhibiting the activation of Wnt/
β
-catenin pathway.
XU F , CHEN J X , YANG X B , et al . Analysis of lung adenocarcinoma subtypes based on immune signatures identifies clinical implications for cancer therapy [J]. Mol Ther Oncolytics , 2020 , 17 : 241 - 249 .
MILLER K D , SIEGEL R L , LIN C C , et al . Cancer treatment and survivorship statistics,2016 [J]. CA Cancer J Clin , 2016 , 66 ( 4 ): 271 - 289 .
DOS SANTOS Á , COOK A W , GOUGH R E , et al . DNA damage alters nuclear mechanics through chromatin reorganization [J]. Nucleic Acids Res , 2021 , 49 ( 1 ): 340 - 353 .
ASHOUR M L , WINK M . Genus Bupleurum :a review of its phytochemistry,pharmacology and modes of action [J]. J Pharm Pharmacol , 2011 , 63 ( 3 ): 305 - 321 .
张耀峰 . 中药柴胡皂苷药理作用的研究进展 [J]. 中医临床研究 , 2020 , 12 ( 33 ): 120 - 121 .
QI X , LIU J , LI X , et al . Saikosaponin a contributed to CCIN treatment by promoting neutrophil bactericidal activity via activation CBL-dependent ERK pathway [J]. Phytomedicine , 2021 , doi: 10.1016/j.phymed.2020.153444 http://dx.doi.org/10.1016/j.phymed.2020.153444 .
WANG H , HUANG Y , SHI J , et al . XPC deficiency leads to centrosome amplification by inhibiting BRCA1 expression upon cisplatin-mediated DNA damage in human bladder cancer [J]. Cancer Lett , 2019 , 444 : 136 - 146 .
SHAO F , LYU X , MIAO K , et al . Enhanced protein damage clearance induces broad drug resistance in multitype of cancers revealed by an evolution drug-resistant model and genome-wide siRNA screening [J]. Adv Sci (Weinh) , 2020 , 7 ( 23 ): 2001914 .
MA Y , YAN Z , DENG X , et al . Anticancer effect of exogenous hydrogen sulfide in cisplatin‑resistant A549/DDP cells [J]. Oncol Rep , 2018 , 39 ( 6 ): 2969 - 2977 .
WANG Q , ZHENG XL , YANG L , et al . Reactive oxygen species-mediated apoptosis contributes to chemosensitization effect of saikosaponins on cisplatin-induced cytotoxicity in cancer cells [J]. J Exp Clin Cancer Res , 2010 , 29 ( 1 ): 159 .
ZHAO X , LIU J , GE S , et al . Saikosaponin A inhibits breast cancer by regulating Th1/Th2 balance [J]. Front Pharmacol , 2019 , 10 : 624 .
YE R P , CHEN Z D . Saikosaponin A,an active glycoside from Radix Bupleuri,reverses P-glycoprotein-mediated multidrug resistance in MCF-7/ADR cells and HepG2/ADM cells [J]. Xenobiotica , 2017 , 47 ( 2 ): 176 - 184 .
CHONG S J F , ISKANDAR K , LAI J X H , et al . Serine-70 phosphorylated Bcl-2 prevents oxidative stress-induced DNA damage by modulating the mitochondrial redox metabolism [J]. Nucleic Acids Res , 2020 , 48 ( 22 ): 12727 - 12745 .
CHEN G , YANG Y , XU Q , et al . Self-amplification of tumor oxidative stress with degradable metallic complexes for synergistic cascade tumor therapy [J]. Nano Lett , 2020 , 20 : 8141 - 8150 .
GAO Y , LIU Z , ZHANG X , et al . Inhibition of cytoplasmic GSK-3 β increases cisplatin resistance through activation of Wnt/ β -catenin signaling in A549/DDP cells [J]. Cancer Lett , 2013 , 336 ( 1 ): 231 - 239 .
CAI J , FANG L , HUANG Y , et al . Publisher correction:simultaneous overactivation of Wnt/ β -catenin and TGF β signalling by miR-128-3p confers chemoresistance-associated metastasis in NSCLC [J]. Nat Commun , 2018 , 9 : 16196 .
WANG Q , QIN Q , SONG R , et al . NHERF1 inhibits beta-catenin-mediated proliferation of cervical cancer cells through suppression of alpha-actinin-4 expression [J]. Cell Death Dis , 2018 , 9 ( 6 ): 668 .
ROGERS C , ERKES D A , NARDONE A , et al . Gasdermin pores permeabilize mitochondria to augment caspase-3 activation during apoptosis and inflammasome activation [J]. Nat Commun , 2019 , 10 ( 1 ): 1689 .
CHEN J C , CHANG N W , CHUNG J G , et al . Saikosaponin-A induces apoptotic mechanism in human breast MDA-MB-231 and MCF-7 cancer cells [J]. Am J Chin Med , 2003 , 31 ( 3 ): 363 - 377 .
0
Views
17
下载量
3
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802024621